January 6, 2014 — Australia’s Therapeutic Goods Administration (TGA) will recall the Smith & Nephew Journey Bi-Cruciate Stabilised (BCS) knee replacement after linking it to a doubled increased risk of premature failure and revision surgery than other knee replacements.
The defective component is the femoral implant/tibial baseplate combination. Patients who have unexpected pain or instability are advised to contact their surgeon or hospital immediately.
According to the safety alert, approximately 7% of Journey BCS knee implants fail within five years, which is nearly twice as high as the 3.8% rate of failure from other knee replacements.
Australian investigators also found a revision rate of 1.59 per 100 observed component years, which is more than twice as high as the 0.72 revision rate associated with other knee implants.
At this time, the Journey BCS is only being recalled in Australia. Smith & Nephew does not advise routine revision surgery unless a patient is experiencing problems. They recommend that surgeons contact their patients to inform them about the problem.
The Journey BCS has been associated with a higher incidence of the following complaints in Australia:
- Patellofermoal pain
- Unspecified pain
Do I have a Smith & Nephew Journey BCS Lawsuit?
The Schmidt Firm, PLLC is currently accepting Smith & Nephew Journey BCS knee replacement injury cases in all 50 states. If you or somebody you know has been injured by a defective knee implant, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Medical Device Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.